跳至主要内容
临床试验/CTRI/2025/05/086844
CTRI/2025/05/086844尚未招募不适用

A COMPARATIVE CLINICAL STUDY OF ABHAYADI GHANAWATI AND TABLET RANITIDINE IN MANAGEMENT OF URDHVAG AMLAPITTA

SELF1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2025年5月19日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
35
试验地点
1
主要终点
4 weeks

研究概览

简要总结

A Randomised Comparative Clinical Trial will be done and patients will be selected in two groups as per the inclusion criteria

Administration of the drug will be for 30 days for Group A and Group B

Followup will be taken at an interval of 7days for 2 weeks

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • patients having signs and symptoms of urdhvag amlapitta as described in ayurvedic samhitas that is chardi,amlodgar,hrullas,hruda kantadaha,udarda,shirashool,hastapada daha,aruchi,maddalotpatti.

排除标准

  • patients suffering gastric ulcers, duodenal ulcers pregnant and lactating women CA stomach,oesophagus,esophageal varices, hematemesis patients having hepatic and renal disorders immunocompromised patients,blood coagulation systemic diseases like HTN,TB,DM.

结局指标

主要结局

4 weeks

时间窗: ABHAYADI GHANAWATI IS EFFECTIVE IN URDHVAG AMLAPITTA

次要结局

未报告次要终点

研究者

发起方
SELF
申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验